Clinical Trials Logo

Clinical Trial Summary

This will be a randomized double-blind placebo-controlled clinical trial that will accept all eligible consecutive patients undergoing elective Kalish bunionectomies. Patients will be randomized into either receiving ketorolac (30 mg IV dose intra-operatively followed by 10 mg orally every 8 hours for five days) plus standard of care or placebo plus standard of care. The purpose of this study is to evaluate the effects of ketorolac plus standard of care on post-operative pain control and radiographic osseous healing. Patients will be assessed for pain via a validated pain questionnaire and for delayed unions via a radiographic scoring system shown to have both high inter- and intra-observer reliability by a blinded board certified radiologist. Additional outcomes of bunionectomy procedures will also be evaluated including adverse events and time to regular shoe gear and activities.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01133639
Study type Interventional
Source Beth Israel Deaconess Medical Center
Contact
Status Terminated
Phase N/A
Start date May 2010
Completion date February 2012

See also
  Status Clinical Trial Phase
Completed NCT01435577 - Intravenous Tapentadol in Post-Bunionectomy Pain Phase 2
Terminated NCT05082012 - Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D) N/A
Terminated NCT03257540 - Early Weight-Bearing After Lapidus Arthrodesis
Completed NCT04518462 - Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries Phase 3
Completed NCT04084262 - Multi-Plane Hallux Valgus Correction With the Phantom® Nail
Active, not recruiting NCT03740282 - Early Weight-Bearing After the Lapiplasty Procedure N/A
Completed NCT01743625 - Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain Phase 3
Completed NCT01484652 - Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension Phase 3
Recruiting NCT05831449 - CPL-01 in the Management of Postoperative Pain After Bunionectomy Phase 3
Completed NCT04826328 - Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy Phase 1
Recruiting NCT05773846 - A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain Phase 3
Completed NCT03653429 - Efficacy of Tranexamic Acid in Foot and Ankle Surgeries Phase 4
Recruiting NCT04751344 - Liposomal Bupivacaine Versus Bupivacaine Plain for Operative Pain Management of Forefoot Surgery Phase 4
Withdrawn NCT03954639 - Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries Phase 3
Completed NCT04002089 - Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy Phase 1
Terminated NCT02499575 - Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures N/A
Completed NCT00613938 - A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy. Phase 3
Completed NCT03246971 - Study of Wafermineâ„¢ for Post-bunionectomy or Abdominoplasty Pain Phase 2
Completed NCT00890682 - Study of Postoperative Analgesia in Bunionectomy Phase 3
Active, not recruiting NCT05602844 - Clinical Trial on Patient-Specific-Instrumentation Assisted Lapidus Fusion for Hallux Valgus N/A